Literature DB >> 21087429

Device closure of patent ductus arteriosus in Marfan patients: safety and effect on the aortic root diameter.

Keyhan S Zanjani1, Abdul Rahim Wong, Masood Sadiq, Howard S Weber, Nancy G Cutler.   

Abstract

OBJECTIVES: There is little evidence in the medical literature about safety of PDA device closure and its effects on aortic root diameter in Marfan patients. We reported on nine Marfan patients whose ducts were occluded by coil or Amplatzer Duct Occluder. PATIENTS AND
INTERVENTIONS: Two patients had aneurismal type E ducts which were closed by a single coil, respectively. The others had conical ducts for which even Amplatzer occluder, stiff, or double coils were used.
RESULTS: No untoward consequence was found during a median follow up period of 18.5 months (range 3 months to 6.33 years). Two patients had small residual shunts. The observed change in the mean ratio of aortic root diameter to its estimated value was statistically insignificant in seven patients who had complete data on their aortic root diameter before PDA closure and during the follow up.
CONCLUSIONS: We concluded that PDA device closure in Marfan patients is safe. Risk of residual shunt is higher even after closure of small ducts.

Entities:  

Mesh:

Year:  2010        PMID: 21087429     DOI: 10.1111/j.1747-0803.2010.00448.x

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  3 in total

1.  Marfan syndrome affecting a whole Sudanese family.

Authors:  Laila M Elmahdi; Sulafa Km Ali
Journal:  Sudan J Paediatr       Date:  2013

2.  Neonatal marfan syndrome: report of two cases.

Authors:  Yazdan Ghandi; Keyhan S Zanjani; Seyed-Eshagh Mazhari-Mousavi; Nima Parvaneh
Journal:  Iran J Pediatr       Date:  2013-02       Impact factor: 0.364

3.  Patent ductus arteriousus device closure in an infant with rubinstein-taybi syndrome.

Authors:  Ehsan Aghaei-Moghadam; Keyhan Sayadpour Zanjani; Yazdan Ghandi
Journal:  Iran J Pediatr       Date:  2013-12       Impact factor: 0.364

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.